April Watt

Postdoc @ University of Melbourne/Peter Mac | cancer biology x cell cycle x epigenetics x CDK2/4/6i

[Shom Goel @shomgoel]

A nice follow-up to our recent @Nature paper (@BarbMarte).

Nature has published a News & Views piece discussing the work: “The secret life of a cell-cycle gatekeeper of cancer.”

Very proud of the team. Interested to hear where these concepts go next.

https://t.co/Rk4UD0oiZB

[Shom Goel @shomgoel]

Delighted to share our new paper, published today in @Nature , led by @AprilCWatt and @AntonioAhnNZ at the @PeterMacCC and The University of Melbourne @uommedia
Paper: https://t.co/eSq2Y8DuSf

[April Watt @AprilCWatt]

Excited to share our work, now in @Nature! Delighted to have co-led this study with co-first author @AntonioAhnNZ under the supervision of @shomgoel at @PeterMacCC @PeterMacRes and the University of Melbourne @uommedia

Open access:
https://t.co/RZSj6kEu75

[Peter Mac Cancer Centre @PeterMacCC]

Peter Mac researchers from @shomgoel's lab have uncovered why breast cancer treatment stops working for some patients.

Published in @Nature, the discovery could help develop new treatment combinations that work for longer and improve outcomes.

More: https://t.co/Awks5JLm22

[Shom Goel @shomgoel]

Congratulations @AprilCWatt on a great talk at @SABCSSanAntonio. Provided the first real explanation of why CDK4/6 inhibitors and endocrine therapy work together, with major implications for understanding resistance and therapy development.

[Shom Goel @shomgoel]

With thanks to @SnowMedical @BCRFcure @CDMRP @TheMarkFdn @PeterMacCC for your support of our work

[Shom Goel @shomgoel]

Happy to share our new study describing the effects of CDK2 inhibition in solid cancers. It has been a fun and stimulating collaboration with @incyclixbio and fantastic to work with INX-315, their selective and potent CDK2 inhibitor.
https://t.co/HTQsoj5lAr…

[The PhD Place @ThePhDPlace]

‘How is your PhD going?’ https://t.co/UadiimgjCG

[April Watt @AprilCWatt]

@vicky__tan @DrAndrewCox @MAF_Dawson @TheDawsonLab Congrats Vicky!

[April Watt @AprilCWatt]

@gsanid @MGHCancerCenter Congratulations Ioannis!

[April Watt @AprilCWatt]

@aj12aj Cysteine is a special one!

[April Watt @AprilCWatt]

@DanielAndrewsMP Please bring back mask mandates and make PCR tests free and accessible to everyone again. RATs are not picking up a lot of the positive cases and are giving people a false sense of safety.

[Emily J Lelliott @Lelliott_EJ]

Can we expand the potential of existing cancer therapies through strategic drug schedules & combinations? Read our perspective on harnessing the immunotherapeutic activity of CDK4/6 inhibitors for combo therapies
https://t.co/gBdRmCXdGZ @PeterMacRes @Nature_NPJ #precisiononcology

[April Watt @AprilCWatt]

@gsanid @RoswellPark Congratulations!

[Shom Goel @shomgoel]

Here's our perspective on targeting CDK4/6, just published in Nature Reviews Cancer @NatureRevCancer @PeterMacRes @UniMelbMDHS @SnowMedical. CDK4/6i's have transformed breast cancer therapy, but we have still only realised a fraction of their potential! https://t.co/9sebdmCG6F

[April Watt @AprilCWatt]

@darioT_ @PiotrOkupski @SpringerNature @BCRJournal @shomgoel Thank you!

[April Watt @AprilCWatt]

Check out our latest review on CDK4/6i in HR+ #breastcancer, published with @SpringerNature in @BCRJournal. We cover research on mechanisms of action beyond cytostasis, summarize current knowledge on acquired resistance, and more… @shomgoel https://t.co/ivk1JDdCzw

[April Watt @AprilCWatt]

@MichaelKuanChi1 @SpringerNature @BCRJournal @shomgoel I wish I had that kind of time now. The bulk of the work was done last year 😄

[April Watt @AprilCWatt]

@PeterMacRes @DrLizChristie Congratulations Liz!

[April Watt @AprilCWatt]

@gsanid @BadriKrishnan5 @purvarumde @TakaakiYasuhara @HanjunLee_MIT @MarcelloStanzi1 @LeeZou8 Amazing! Congratulations!